Related Experiment Video
Updated: Jan 19, 2026

Isolation of Intrapulmonary Artery and Smooth Muscle Cells to Investigate Vascular Responses
Published on: June 8, 2022
How to identify and manage non-response to clozapine?
Mujeeb U Shad1, Emma Felzien2, Kamalika Roy3
1School of Medicine, Oregon Health & Science University, Portland, Oregon, United States; Department of Psychiatry, Oregon State Hospital, Salem, Oregon, United States; Samaritan Mental Healthcare System, Corvallis, Oregon, United States.
Abstract:
Clozapine is the only approved treatment for Treatment-Refractory Schizophrenia. Here we describe a case series of three hospitalized patients with clozapine nonresponse. One of them responded to clozapine after dose adjustments were made for an interaction between clozapine and ciprofloxacin. The other two cases remained clozapine nonresponders despite optimizing clozapine treatment. However, both these patients responded to other antipsychotic medications (APMs) with better tolerability than observed with clozapine treatment. This case series focuses on diagnosing a genuine from a pseudo-nonresponse to clozapine and to consider other APMs in genuine nonresponse before switching to invasive interventions, such as ECT.
Related Concept Videos
Applications of GIS: Disaster Management and Emergency Response
07:56Isolation of Intrapulmonary Artery and Smooth Muscle Cells to Investigate Vascular Responses
07:05Quantifying Food Intake in Caenorhabditis elegans by Measuring Bacterial Clearance
10:45A Community-based Stress Management Program: Using Wearable Devices to Assess Whole Body Physiological Responses in Non-laboratory Settings
Tonsillitis II: Management
Impression Management Techniques I: Managing Appearances
